Clinical Trial Update: Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the radiolabeled imaging agent AV94 with SPECT in individuals with Alzheimer disease compared to healthy controls; the trial is termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AV94 (AV94)

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Alzheimer Disease | Phase 1 | Status: TERMINATED